Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 2Other solid neoplasm 2Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Melanoma 1654Skin Neoplasms 355Lymphoma, T-Cell, Cutaneous 322Carcinoma, Basal Cell 240Mycosis Fungoides 227Sezary Syndrome 209Breast Neoplasms 196Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 183Lymphoma, Large B-Cell, Diffuse 183Lymphoma, B-Cell, Marginal Zone 182Lymphoma, Mantle-Cell 181Hodgkin Disease 175Lymphoma 173Burkitt Lymphoma 173Uveal Melanoma 170Lymphoma, Large-Cell, Immunoblastic 168Multiple Myeloma 159Keratosis, Actinic 146Neoplasms 142Leukemia, Myeloid, Acute 134Neoplasm Metastasis 125Lymphoma, Large-Cell, Anaplastic 125Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 123Lung Neoplasms 120Immunoblastic Lymphadenopathy 115Leukemia, Myeloid, Accelerated Phase 113Leukemia, Myeloid, Chronic-Phase 112

Interventions

atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Mucinous × Dermatologic × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡